Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Clinical trial NCT06804850 · WITHDRAWN

Trial details

NCT number: NCT06804850
Sponsor: West China Hospital
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer

Start date: 2025-01-20
Primary completion: 2026-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.